Cargando…
An Osteoprotegerin Gene Polymorphism Is Associated with an Increased Risk of Hip Fracture in Japanese Patients with Rheumatoid Arthritis: Results from the IORRA Observational Cohort Study
INTRODUCTION: Patients with rheumatoid arthritis (RA) have a higher prevalence of osteoporosis and hip fracture than healthy individuals. Multiple genetic loci for osteoporotic fracture were identified in recent genome-wide association studies. The purpose of this study was to identify genetic varia...
Autores principales: | Yoshida, Shinji, Ikari, Katsunori, Furuya, Takefumi, Toyama, Yoshiaki, Taniguchi, Atsuo, Yamanaka, Hisashi, Momohara, Shigeki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126739/ https://www.ncbi.nlm.nih.gov/pubmed/25105978 http://dx.doi.org/10.1371/journal.pone.0104587 |
Ejemplares similares
-
A GC polymorphism associated with serum 25-hydroxyvitamin D level is a risk factor for hip fracture in Japanese patients with rheumatoid arthritis: 10-year follow-up of the Institute of Rheumatology, Rheumatoid Arthritis cohort study
por: Yoshida, Shinji, et al.
Publicado: (2014) -
PADI4 and HLA-DRB1 Are Genetic Risks for Radiographic Progression in RA Patients, Independent of ACPA Status: Results from the IORRA Cohort Study
por: Suzuki, Taku, et al.
Publicado: (2013) -
Studies of the efficacy and safety of methotrexate at dosages over 8 mg/week using the IORRA cohort database
por: Seto, Yohei, et al.
Publicado: (2011) -
Response to ‘Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study’
por: Ikari, Katsunori, et al.
Publicado: (2014) -
Features of patients with rheumatoid arthritis whose debut joint is a foot or ankle joint: A 5,479-case study from the IORRA cohort
por: Yano, Koichiro, et al.
Publicado: (2018)